Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/2800
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sutherland, I A | - |
dc.coverage.spatial | 21 | en |
dc.date.accessioned | 2008-11-04T11:42:42Z | - |
dc.date.available | 2008-11-04T11:42:42Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Current Opinion in Drug Discovery & Development. 10 (6) 540-549 | en |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/2800 | - |
dc.description.abstract | The future challenges in bioprocessing include developing new downstream processes for the purification and manufacture of the protein based medicines of the future to relieve the predicted bottleneck being produced by increasingly high titres from fermentation processes. This review looks at the recent developments in centrifugal liquid-liquid partition chromatography using aqueous two-phase solvent (ATPS) systems, a gentle host medium for biologics, and the prospect for scale-up and eventual manufacture of high value pharmaceutical products. | en |
dc.format.extent | 1806336 bytes | - |
dc.format.mimetype | application/msword | - |
dc.language.iso | en | - |
dc.publisher | BioMed Central | en |
dc.subject | Aqueous two-phase solvents, ATPS, aqueous-aqueous polymer phase systems, centrifugal partition chromatography, CPC, Countercurrent chromatography, CCC, HSCCC | en |
dc.title | Review of centrifugal liquid-liquid chromatography using aqueous two-phase solvent (ATPS) systems: Its scale-up and prospects for the future production of high-value biologics | en |
dc.type | Research Paper | en |
Appears in Collections: | Brunel Institute for Bioengineering (BIB) Biological Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ReviewPaper-Final4F.pdf | 3.41 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.